CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 79 filers reported holding CYTOSORBENTS CORP in Q2 2022. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $116,430 | -47.6% | 61,931 | 0.0% | 0.00% | – |
| Q2 2023 | $222,332 | +7.3% | 61,931 | +0.7% | 0.00% | – |
| Q1 2023 | $207,231 | +113.9% | 61,493 | -1.6% | 0.00% | – |
| Q4 2022 | $96,860 | +16.7% | 62,490 | +1.9% | 0.00% | – |
| Q3 2022 | $83,000 | -38.1% | 61,339 | +0.6% | 0.00% | – |
| Q2 2022 | $134,000 | -27.2% | 60,977 | +5.7% | 0.00% | – |
| Q1 2022 | $184,000 | -7.5% | 57,684 | +21.3% | 0.00% | – |
| Q4 2021 | $199,000 | – | 47,543 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skylands Capital, LLC | 815,869 | $3,141,000 | 0.46% |
| Sargent Investment Group, LLC | 499,010 | $1,921,000 | 0.36% |
| Anson Funds Management LP | 74,440 | $287,000 | 0.33% |
| One68 Global Capital, LLC | 39,241 | $151,000 | 0.33% |
| Granahan Investment Management | 678,618 | $2,613,000 | 0.12% |
| Winning Points Advisors, LLC | 30,000 | $115,000 | 0.07% |
| Avenir Corp | 150,600 | $580,000 | 0.06% |
| HighMark Wealth Management LLC | 10,000 | $38,000 | 0.04% |
| Wealthcare Advisory Partners LLC | 62,279 | $240,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 64,970 | $250,000 | 0.03% |